Jpmorgan Chase & CO Kura Oncology, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 409,241 shares of KURA stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

409,241

Previous 406,149 0.76%

Holding current value

$3.69 Million

Previous $8.36 Million 4.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$18.57 - $23.23 $57,418 - $71,827	3,092 Added 0.76%	409,241 $8 Million
Q2 2024 Aug 12, 2024	SELL	$17.53 - $22.98 $495,169 - $649,116	-28,247 Reduced 6.5%	406,149 $8.36 Million
Q1 2024 May 10, 2024	SELL	$13.42 - $23.53 $517,958 - $908,163	-38,596 Reduced 8.16%	434,396 $9.27 Million
Q4 2023 Feb 12, 2024	SELL	$7.58 - $14.38 $67,287 - $127,651	-8,877 Reduced 1.84%	472,992 $6.8 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $173,712 - $244,102	-20,582 Reduced 4.1%	481,869 $4.39 Million
Q2 2023 Aug 11, 2023	SELL	$9.62 - $13.99 $103,617 - $150,686	-10,771 Reduced 2.1%	502,451 $5.32 Million
Q1 2023 May 18, 2023	BUY	$10.71 - $14.6 $862,701 - $1.18 Million	80,551 Added 18.62%	513,222 $6.28 Million
Q1 2023 May 11, 2023	SELL	$10.71 - $14.6 $870,101 - $1.19 Million	-81,242 Reduced 15.81%	432,671 $5.29 Million
Q4 2022 Feb 13, 2023	SELL	$11.23 - $16.9 $389,916 - $586,784	-34,721 Reduced 6.33%	513,913 $6.38 Million
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $155,721 - $252,188	-12,966 Reduced 2.31%	548,634 $7.5 Million
Q2 2022 Aug 11, 2022	BUY	$10.71 - $18.33 $5.15 Million - $8.81 Million	480,848 Added 595.46%	561,600 $10.3 Million
Q1 2022 May 11, 2022	SELL	$11.78 - $16.98 $298,128 - $429,729	-25,308 Reduced 23.86%	80,752 $1.3 Million
Q4 2021 Feb 10, 2022	BUY	$12.22 - $19.57 $617,684 - $989,204	50,547 Added 91.05%	106,060 $1.49 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $856,010 - $1.21 Million	55,513 New	55,513 $1.04 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Kura Oncology, Inc. Transaction History